Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Loai Tahat"'
Autor:
Andrew Hill, Loai Tahat, Mohammed Khalil Mohammed, R.abab Fayez Tayyem, Giten Khwairakpam, Sanjay Nath, James Freeman, Ismahane Benbitour, Sherine Helmy
Publikováno v:
Journal of Virus Eradication, Vol 4, Iss 2, Pp 128-131 (2018)
Mass production of low-cost, generic direct-acting antivirals (DAAs) will be required to achieve targets of eliminating hepatitis C (HCV) by 2030. The pharmaceutical companies Gilead and Bristol-Myers Squibb have granted voluntary licences (VLs) to g
Externí odkaz:
https://doaj.org/article/1d07af137e204cb7baf12f9e3413095f
Autor:
Sherine Helmy, Giten Khwairakpam, Mohammed Khalil Mohammed, Rabab Fayez Tayyem, Sanjay Nath, Ismahane Benbitour, James Freeman, Loai Tahat, Andrew Hill
Publikováno v:
Journal of Virus Eradication
Journal of Virus Eradication, Vol 4, Iss 2, Pp 128-131 (2018)
Journal of Virus Eradication, Vol 4, Iss 2, Pp 128-131 (2018)
Mass production of low-cost, generic direct-acting antivirals (DAAs) will be required to achieve targets of eliminating hepatitis C (HCV) by 2030. The pharmaceutical companies Gilead and Bristol-Myers Squibb have granted voluntary licences (VLs) to g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::920ba48ac111bc1784bfc54db90fe2b1
https://pubmed.ncbi.nlm.nih.gov/29682307
https://pubmed.ncbi.nlm.nih.gov/29682307